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Background
Patients with uncontrolled CRS have persistent bother-
some symptoms despite appropriate treatment with nasal
corticosteroids and endoscopic sinus surgery. The aim of
this study was to identify which T cell subtype of
untreated, steroid naive CRSwNP and CRSsNP patients
influences the disease control.
Methods
CRS was diagnosed based on symptoms, nasal endoscopy
and CT scan. Sinonasal mucosa (uncinate process) or
middle meatal polyp tissue were obtained from 31
untreated CRS patients (18 CRSwNP and 13 CRSsNP)
and analyzed histopathologicaly and by flow cytometry.
Patients were subsequently treated medically and if unre-
sponsive surgically. The average follow up duration was
15,8 ± 4,6 months after tissue sampling. Patients with
persistent symptoms on VAS ≥5 despite treatment repre-
sented the uncontrolled CRS group.
Results
The CRSwNP group had significantly more CD4+ cells
then CRSsNP group (34,05±19.89 vs. 22,04±16.71,
p=0.028) and significantly less CD8+ cells then CRSsNP
group (56,94±11.76 vs. 67.15±23.22, p=0.002). All
uncontrolled CRSwNP patients had tissue eosinophilia. In
the well-controlled CRSwNP there were significantly more
Th17 CD4+CCR6+ cells (13.28±5.96) then in the uncon-
trolled CRSwNP (7.16±4.89), p=0.046. In the uncontrolled
CRSwNP there were significantly more double negative
T17 CD4-CD8-CCR6+ cells (12.20; IQR 2.20-21.8) then in
the well-controlled CRSwNP group (5.40; IQR 1.65-9.15),
p=0,010. In the uncontrolled CRSsNP group there were
significantly more cytotoxic CD3+CD8+ cells (79.86±7.86)
then in the well-controlled CRSsNP group (52.95±28.17),
p= 0.045. In the well-controlled CRSsNP group there were
significantly more double negative CD4-CD8- cells
(46.93±28.29) then in the uncontrolled CRSsNP group
(20.70±7.59), p = 0.019.
Conclusions
By flow cytometry we were able to show the Th17 CD4
+CCR6+ cell to predict well-controlled CRSwNP; we
could explain that by Th17 cell plasticity, being able to
transform into Th1 cell. Double negative T17 CD4-CD8-
CCR6+ cell (also capable of IL-17 production) predicted
uncontrolled CRS; double negative T17 cells are known to
promote immune cell recruitment and tissue immunoglo-
bulin production in autoimmune diseases. In CRSsNP
being cytotoxic type of inlammation the Tc CD8+ cell pre-
dicted the uncontrolled disease. The double negative CD4-
CD8- predicted the well-controlled CRSsNP which could
be the result of CD8 silencing.
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